An2 Therapeutics, Inc. · NASDAQ:ANTX
Adjuvant Capital GP, L.P. reported a 7.90% stake in An2 Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 28, 2025
Adjuvant Capital GP, L.P. reported a 7.90% stake in An2 Therapeutics, Inc., 2,373,500 shares, as a passive investor on Dec 31, 2024. Filed Feb 28, 2025 (Schedule 13G/A).
- Stake
- 7.90%
- Shares
- 2,373,500
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adjuvant Global Health Technology Fund, L.P. | 6.70% | 1,995,958 |
| Adjuvant Global Health Technology Fund DE, L.P. | 1.30% | 377,542 |
| Adjuvant Capital GP, L.P. | 7.90% | 2,373,500 |
| Adjuvant Capital Management, L.L.C. | 7.90% | 2,373,500 |